Add BrightSurf on Google Email

University of California - Irvine


UC Irvine study shows similarities and differences in human and insect vision formation

A recent UCI study found profound similarities between humans and insects in producing the critical light-absorbing molecule of the retina, 11-cis-retinal. The research provides new insights into retinal disease origins and potential therapeutic targets, with implications for understanding loss-of-function mutations in RPE65.

SourceUniversity of California - Irvine·JournalNature Chemical Biology·DateFeb 22, 2024

UC Irvine-led team unravels mysteries of planet formation and evolution in distant solar system

Astronomers at the University of California, Irvine, have compiled precise measurements of six exoplanets in a recently discovered solar system. The team used a combination of radial velocity analysis and transit timing variations to determine the planets' masses and orbital properties.

SourceUniversity of California - Irvine·JournalThe Astronomical Journal·TypeObservational study·DateJan 26, 2024

UC Irvine researchers discover how to better support lab grown muscle cells after transplantation.

Researchers at UC Irvine have identified a critical gene for muscle repair and regeneration, enabling the creation of muscle in the lab that can support human stem cells. The discovery has immense implications for treating various chronic muscle disorders and injuries, including rotator cuff tears and Duchenne Muscular Dystrophy.

SourceUniversity of California - Irvine·JournalNature Cell Biology·TypeExperimental study·DateNov 9, 2023

UCI researchers announce publication of an open-label clinical trial suggesting that N-acetylglucosamine restores neurological function in Multiple Sclerosis patients

A study published by UCI researchers found that N-acetylglucosamine reduced multiple inflammation and neurodegeneration markers in patients with Multiple Sclerosis. The dietary supplement also improved neurological function in 30% of patients, suggesting a potential new treatment for the condition.

SourceUniversity of California - Irvine·JournalJournal of Neuroinflammation·TypeRandomized controlled/clinical trial·DateSep 14, 2023

Researchers at UC Irvine issue a warning that GLP-1RA’s may be dangerous for children

Researchers at UC Irvine issue a warning that GLP-1RA's may be dangerous for children due to the risk of nutrient imbalance and abuse. The team notes that children need energy and sufficient calories for growth and development, and any change in their diet and exercise balance can have long-term health consequences.

SourceUniversity of California - Irvine·JournalClinical and Translational Science·TypeData/statistical analysis·DateAug 28, 2023

Recent study at UC Irvine found that semaglutide medication may benefit 93 million U.S. adults

A recent study at UC Irvine found that semaglutide medication can lead to significant weight loss and reduce cardiovascular risk in 93 million U.S. adults. The medication may prevent up to 1.5 million heart attacks and strokes over 10 years, resulting in 43 million fewer obese people.

SourceUniversity of California - Irvine·JournalCardiovascular Drugs and Therapy·TypeData/statistical analysis·DateAug 15, 2023

UC Irvine scientists develop freely available risk model for hurricanes, tropical cyclones

A team of researchers at UC Irvine has developed a freely available computer model to estimate the economic costs of hurricanes and typhoons. The model combines data from climate change science and household vulnerability information, providing return periods of asset losses and helping countries better prepare for these disasters.

SourceUniversity of California - Irvine·JournalWeather Climate and Society·DateJun 27, 2023

New research may explain why, despite “the munchies”, frequent cannabis users are leaner than non-users

Researchers have uncovered a possible explanation for why frequent cannabis users are leaner and less prone to diabetes than non-users. The study found that adolescent exposure to low-dose THC disrupts energy balance and adipose organ homeostasis in adulthood, leading to reduced fat mass and increased lean mass.

SourceUniversity of California - Irvine·JournalCell Metabolism·DateJun 1, 2023

UC Irvine-led interdisciplinary team delves into a heated debate about humidity

A UC Irvine-led interdisciplinary team highlights a dispute between physiologists and epidemiologists about the role of humidity in heat stress. The authors argue that humid conditions exacerbate heat-related illnesses, particularly in tropical nations, and call for more accurate models to predict future health impacts.

SourceUniversity of California - Irvine·JournalEnvironmental Health Perspectives·DateMay 31, 2023

New UCI-led research shows people who live to be 90+ with superior thinking skills are resilient to Alzheimer’s pathology in their brains

A UCI-led study reveals that the oldest-old, those living up to 90 years old, exhibit similar levels of brain pathology as Alzheimer's patients but with lower levels of pathology from other neurodegenerative diseases. This finding suggests these individuals may be resistant to these age-related cognitive decline.

SourceUniversity of California - Irvine·JournalJournal of Alzheimer’s Disease·DateMay 24, 2023

UC Irvine research team identifies glycosylation enzyme critical in brain formation

A UC Irvine research team discovered that the MGAT5 glycosylation enzyme plays a critical role in brain development. The study found that neural stem cells use glycosylation to regulate their reactions to external signals and develop mature brain cells. This discovery may contribute to new therapeutic purposes for neural stem cells.

SourceUniversity of California - Irvine·JournalStem Cell Reports·DateMay 16, 2023

UCI researchers discover new drugs with potential for treating world’s leading causes of blindness in age-related and inherited retinal diseases

Researchers at UCI have discovered new small-molecule drugs that show promise in treating age-related macular degeneration, diabetic retinopathy, and retinitis pigmentosa. The treatments, called 'Stress Resilience-Enhancing Drugs,' slow or halt disease progression in animal models.

SourceUniversity of California - Irvine·JournalProceedings of the National Academy of Sciences·DateMay 8, 2023